UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
---------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
NOVEMBER 2, 1999
Date of Report (Date of earliest event reported)
ABBOTT LABORATORIES
(Exact name of registrant as specified in its charter)
---------------------
ILLINOIS 1-2189 36-0698440
(State or other (Commission File Number) (I.R.S. Employer
Jurisdiction of Identification No.)
Incorporation)
---------------------
100 ABBOTT PARK ROAD
ABBOTT PARK, ILLINOIS 60064-6400
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (847) 937-6100
---------------------
ITEM 5. OTHER EVENTS.
On September 28, 1999, Abbott announced that it had been notified by
the United States government of alleged noncompliance with the Food and Drug
Administration's Quality System Regulation at Abbott's Diagnostics Division
facilities in Lake County, Illinois. On November 2, 1999, a consent decree was
entered in the United States District Court for the Northern District of
Illinois which settles the issues involving Abbott's diagnostic manufacturing
operations in Lake County, Illinois. The consent decree is more fully described
in the press release attached as Exhibit 99.1. A copy of the consent decree is
attached as Exhibit 99.2.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
EXHIBIT NO. DESCRIPTION
Exhibit 99.1 Press Release dated November 2, 1999.
Exhibit 99.2 Consent Decree.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
ABBOTT LABORATORIES
/s/ Gary P. Coughlan
-------------------------------
By: Gary P. Coughlan
Senior Vice President, Finance
and Chief Financial Officer
Date: November 4, 1999